Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival-Reference-Cited by-同舟云学术

Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival

Published:2005-08 Issue:4 Volume:130 Page:542-548
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lovell Richard,Dunn Janet A.,Begum Gulnaz,Barth Nicola J.,Plant Tim,Moss Paul A.,Drayson Mark T.,Pratt Guy,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05647.x/fullpdf

Reference33 articles.

1. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival

2. Syndecan-1 in Multiple Myeloma: Relationship to Conventional Prognostic Factors

3. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

4. Impact of response to treatment on survival in multiple myeloma: results in a series of 243 patients

5. Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Control of tissue homeostasis by the extracellular matrix: Synthetic heparan sulfate as a promising therapeutic for periodontal health and bone regeneration;Periodontology 2000;2023-08-24

2. Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma;Pathology and Oncology Research;2023-04-28

3. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition;American Journal of Physiology-Cell Physiology;2022-07-01

4. Targeting syndecan-1: new opportunities in cancer therapy;American Journal of Physiology-Cell Physiology;2022-07-01

5. Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers;The Extracellular Matrix and the Tumor Microenvironment;2022